- Tytuł:
- PMS66 - Impact of Golimumab, An Anti-Tnfα Monoclonal Antibody, On Health Related Quality of Life (Hrqol) And Work Productivity In Patients With Active Psoriatic Arthritis: 24-Week Results of The Phase Iii Go Vibrant Trial
- Autorzy:
- Źródło:
- In Value in Health October-November 2017 20(9):A538-A538
Czasopismo naukowe